Maria Gardberg

Summary

Affiliation: University of Turku
Country: Finland

Publications

  1. pmc Characterization of Diaphanous-related formin FMNL2 in human tissues
    Maria Gardberg
    Department of Pathology, University of Turku and Turku University Central Hospital, Turku, Finland
    BMC Cell Biol 11:55. 2010
  2. pmc Characterization of Leukocyte Formin FMNL1 Expression in Human Tissues
    Maria Gardberg
    Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland MG, VDH, OC Medical Biotechnology, VTT Technical Research Centre of Finland, and Turku Centre for Biotechnology, University of Turku, Turku, Finland KI Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden CK Science for Life Laboratory and Albanova University Center Royal Institute of Technology, Stockholm, Sweden MU
    J Histochem Cytochem 62:460-470. 2014
  3. pmc FHOD1, a formin upregulated in epithelial-mesenchymal transition, participates in cancer cell migration and invasion
    Maria Gardberg
    Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland
    PLoS ONE 8:e74923. 2013
  4. doi request reprint Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival
    Aida Kiviniemi
    Department of Radiology, Turku University Hospital, University of Turku, Kiinamyllynkatu 4 8, 20521, Turku, Finland
    J Neurooncol 124:237-45. 2015
  5. doi request reprint Comparison of Somatostatin Receptor 2-Targeting PET Tracers in the Detection of Mouse Atherosclerotic Plaques
    Petteri Rinne
    Turku PET Centre, Turku University Hospital and University of Turku, Kiinamyllynkatu 4 8, FI 20520, Turku, Finland
    Mol Imaging Biol 18:99-108. 2016
  6. doi request reprint Midbrain-to-pons ratio in autopsy-confirmed progressive supranuclear palsy: replication in an independent cohort
    Valtteri Kaasinen
    Division of Clinical Neurosciences, Turku University Hospital and University of Turku, POB 52, 20521, Turku, Finland
    Neurol Sci 36:1251-3. 2015
  7. doi request reprint Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies
    Aida Kiviniemi
    Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland
    Acta Oncol 53:1125-34. 2014
  8. doi request reprint Brain ¹⁸F-FDG and ¹¹C-PiB PET findings in two siblings with FTD/ALS associated with the C9ORF72 repeat expansion
    Mika H Martikainen
    a Department of Neurology, University of Turku and Turku University Hospital, Turku, Finland
    Neurocase 20:150-7. 2014

Collaborators

Detail Information

Publications8

  1. pmc Characterization of Diaphanous-related formin FMNL2 in human tissues
    Maria Gardberg
    Department of Pathology, University of Turku and Turku University Central Hospital, Turku, Finland
    BMC Cell Biol 11:55. 2010
    ..In spite of this, very little is known of the tissue distribution and cellular location of any mammalian formin. Here we have carried out a comprehensive analysis of the formin family member formin -like 2 (FMNL2) in human tissues...
  2. pmc Characterization of Leukocyte Formin FMNL1 Expression in Human Tissues
    Maria Gardberg
    Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland MG, VDH, OC Medical Biotechnology, VTT Technical Research Centre of Finland, and Turku Centre for Biotechnology, University of Turku, Turku, Finland KI Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden CK Science for Life Laboratory and Albanova University Center Royal Institute of Technology, Stockholm, Sweden MU
    J Histochem Cytochem 62:460-470. 2014
    ..Our results indicate that FMNL1 expression is not restricted to hematopoietic tissues and that neoexpression of FMNL1 can be seen in epithelial cancer...
  3. pmc FHOD1, a formin upregulated in epithelial-mesenchymal transition, participates in cancer cell migration and invasion
    Maria Gardberg
    Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland
    PLoS ONE 8:e74923. 2013
    ..Our results indicate that FHOD1 participates in cytoskeletal changes in EMT. In addition, we show that FHOD1 upregulation occurs during cancer cell EMT in vivo, which indicates that FHOD1 may contribute to tumour progression. ..
  4. doi request reprint Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival
    Aida Kiviniemi
    Department of Radiology, Turku University Hospital, University of Turku, Kiinamyllynkatu 4 8, 20521, Turku, Finland
    J Neurooncol 124:237-45. 2015
    ..Our results suggest that circulating EGFR is not derived from glioma cells and cannot be used as a marker for EGFR status in the tumor. ..
  5. doi request reprint Comparison of Somatostatin Receptor 2-Targeting PET Tracers in the Detection of Mouse Atherosclerotic Plaques
    Petteri Rinne
    Turku PET Centre, Turku University Hospital and University of Turku, Kiinamyllynkatu 4 8, FI 20520, Turku, Finland
    Mol Imaging Biol 18:99-108. 2016
    ..We aimed to investigate whether somatostatin receptor-targeting positron emission tomography (PET) tracers, [(68)Ga]DOTANOC, [(18)F]FDR-NOC, and [(68)Ga]DOTATATE, can detect inflamed atherosclerotic plaques...
  6. doi request reprint Midbrain-to-pons ratio in autopsy-confirmed progressive supranuclear palsy: replication in an independent cohort
    Valtteri Kaasinen
    Division of Clinical Neurosciences, Turku University Hospital and University of Turku, POB 52, 20521, Turku, Finland
    Neurol Sci 36:1251-3. 2015
    ..8 %. The results of this second autopsy-confirmed sample confirm that midbrain-to-brain ratios constitute reliable and clinically useful estimates of diagnostic midbrain atrophy in relation to PSP pathology...
  7. doi request reprint Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies
    Aida Kiviniemi
    Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland
    Acta Oncol 53:1125-34. 2014
    ..The purpose of this study was to evaluate sstr2 status in experimental BT4C malignant gliomas...
  8. doi request reprint Brain ¹⁸F-FDG and ¹¹C-PiB PET findings in two siblings with FTD/ALS associated with the C9ORF72 repeat expansion
    Mika H Martikainen
    a Department of Neurology, University of Turku and Turku University Hospital, Turku, Finland
    Neurocase 20:150-7. 2014
    ..His sister was diagnosed with FTD, and the C9ORF72 expansion was detected in both siblings. We conclude that ¹¹C-PiB PET imaging may help the early differential diagnosis between AD and FTD, including C9FTD/ALS...